Physiological Dead Space and Intensive Care Mortality in Mechanically Ventilated Patients
IRIS-MAP
Investigation of the Relationship Between Physiological Dead Space and Intensive Care Unit Mortality in Mechanically Ventilated Adult Patients: A Prospective Observational Study
1 other identifier
observational
60
1 country
1
Brief Summary
This study investigates the relationship between physiological dead space and clinical outcomes, specifically mortality and discharge status, in adult patients receiving invasive mechanical ventilation in the intensive care unit (ICU). Physiological dead space refers to ventilated but non-perfused regions of the lungs and can be quantified using the Enghoff-modified Bohr equation based on capnographic and arterial CO₂ measurements. While volumetric capnography is a valuable tool in anesthesiology and perioperative care, its use in ICU settings remains limited. By continuously monitoring physiological dead space at the bedside, this study aims to provide real-time insight into ventilation-perfusion mismatch and assess its prognostic significance in critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2025
CompletedFirst Submitted
Initial submission to the registry
April 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 9, 2025
CompletedMay 9, 2025
April 1, 2025
1.3 years
April 20, 2025
April 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ICU Mortality
All-cause mortality during the intensive care unit (ICU) stay.
Up to ICU discharge day or 28 day
Secondary Outcomes (4)
ICU Length of Stay
Through ICU stay, up to 28 days
Mechanical Ventilation Duration
From initiation of invasive mechanical ventilation to extubation or death or, up to 28 days
Change in Physiological Dead Space Over Time
Daily measurements for up to 3 days in the ICU
Relationship Between Physiological Dead Space and Oxygenation
Daily during ICU stay (up to 3 days)
Study Arms (1)
Mechanically Ventilated Adult ICU Patients
Adult patients (aged ≥18 years) who received invasive mechanical ventilation in a tertiary intensive care unit. All participants were prospectively monitored with volumetric capnography and arterial blood gas analysis to evaluate physiological dead space. No interventions were applied as part of the study.
Eligibility Criteria
The study population consisted of adult patients (aged 18 years and older) who were admitted to a tertiary academic intensive care unit and required invasive mechanical ventilation for respiratory failure of various etiologies. All patients were managed in the ICU setting with advanced monitoring capabilities, including arterial blood gas analysis and volumetric capnography. Patients were enrolled consecutively during the study period based on predefined eligibility criteria. Individuals with hemodynamic instability, severe acidosis, or technical limitations preventing accurate dead space measurement were excluded. The study population reflects a critically ill cohort typically encountered in university hospital ICUs.
You may qualify if:
- Admitted to the intensive care unit
- Receiving invasive mechanical ventilation
- Monitored with volumetric capnography and arterial blood gas analysis
- Informed consent obtained from legal representatives
You may not qualify if:
- Patients under 18 years of age
- ICU length of stay less than 24 hours
- Patient or legal representative refused participation
- Hemoglobin level \< 7 g/dL
- Arterial PaCO₂ \> 70 mmHg
- Signs of circulatory failure
- Lactate \> 4 mmol/L
- Capillary refill time \> 3 seconds
- PaCO₂ - Central venous CO₂ gradient \> 8 mmHg (if applicable)
- Mean arterial pressure (MAP) \< 65 mmHg
- Mottling score ≥ 2
- Body temperature \> 38°C
- Arterial pH \< 7.20
- Body mass index (BMI) \> 40 kg/m²
- Carbon dioxide production (VCO₂) \> 4 mL/kg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karadeniz Technical University
Trabzon, 61080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehtap Pehlivanlar Kucuk, MD, Assoc. Prof.
Karadeniz Technical University, Faculty of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Assist. Prof.
Study Record Dates
First Submitted
April 20, 2025
First Posted
May 9, 2025
Study Start
January 1, 2024
Primary Completion
April 19, 2025
Study Completion
April 19, 2025
Last Updated
May 9, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to privacy considerations and the lack of a formal data-sharing infrastructure for this study.